The Global Health Bureau, Office of Health, Infectious Disease and Nutrition (HIDN), US Agency for International Development (USAID, Washington DC, USA), financially supports this study through Challenge TB under the terms of Agreement No. AID-OAA-A-14-00029. The authors’ views expressed in this publication do not necessarily reflect the views of the USAID or US Government. Conflicts of interest: none declared.
*Oxford Health Evaluations, Oxford, UK; †KIT Royal Tropical Institute, Amsterdam; ‡KNCV Tuberculosis Foundation, The Hague, The Netherlands; §Global Tuberculosis Institute, Rutgers, The State University of New Jersey, Newark, New Jersey, USA; ¶London School of Tropical Medicine & Hygiene, London, UK; #Zambart, University of Zambia, Lusaka, Zambia; **Human Sciences Research Council, Durban, South Africa; ††US Agency for International Development Global Health Bureau, Washington DC, USA; ‡‡Centre for Research in Primary and Community Care, School of Health and Social Work, University of Hertfordshire, Hatfield, UK; §§Amsterdam Institute for Global Health and Development, Amsterdam, The Netherlands; ¶¶Department of Epidemiology, McGill University, Montreal, Quebec, Canada; ##Department of Health, Ethics & Society/Care And Public Health Research Institute, University of Maastricht, Maastricht, The Netherlands; ***The Work for Change/Irish Forum for Global Health, Dublin, Ireland; †††Global TB Programme, World Health Organization, Geneva, Switzerland; ‡‡‡Institute for Medicine and Public Health, Vanderbilt University, Nashville, Tennessee, USA; §§§University of Sydney, Sydney, New South Wales, Australia; ¶¶¶Department of Sociology, Centre for Longitudinal and Life Course Studies, University of Antwerp, Antwerp, Belgium; ###International Center for Research on Women, Stigma Action Network Secretariat, Washington DC, USA; ****University of Antwerp, Antwerp, Belgium; ††††Netherlands Leprosy Relief, Amsterdam, The Netherlands; ‡‡‡‡Department of Epidemiology, University of Ottawa, Ontario, Canada